Related Experiment Video
Updated: Aug 27, 2025
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
[Guillain-Barré syndrome and cytomegalovirus]
Elyanne Gault1, David Orlikowski2, Jean-Louis Gaillard1
1AP-HP, hôpital Ambroise-Paré, laboratoire de microbiologie, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France, Université de Versailles - Saint-Quentin-en-Yvelines, 9, boulevard d'Alembert, 78280 Guyancourt, France.
Abstract:
Guillain-Barré syndrome (GBS) is the leading cause of acute flaccid paralysis in developed countries. It usually follows an infectious disease, cytomegalovirus (CMV) being one of the most frequently identified triggering agents. Little is known about the epidemiology and the prognostic factors of GBS following primary infection by CMV. We analyzed clinical and biological data from over 500 patients hospitalized from 1996 to 2006 in a French reference centre for GBS, and identified 63 cases of CMV-associated GBS. Our results confirm some of the clinical features previously described. We also report some new insights into the epidemiology and the prognostic factors of the disease. Finally, our results suggest a possible involvement of viral replication in the neuropathological processes of CMV-GBS, but this point requires further investigation.
Insights
Guillain-Barré syndrome (GBS) following cytomegalovirus (CMV) infection is analyzed. This study identifies epidemiological and prognostic factors, suggesting viral replication may play a role in CMV-GBS neuropathology.
Area of Science:
- Neurology
- Infectious Diseases
- Epidemiology
Context:
- Guillain-Barré syndrome (GBS) is a primary cause of acute flaccid paralysis.
- Cytomegalovirus (CMV) is a frequent trigger for GBS.
- Limited data exists on the epidemiology and prognosis of CMV-associated GBS.
Purpose:
- To investigate the epidemiology and prognostic factors of GBS following primary CMV infection.
- To analyze clinical and biological data from a cohort of CMV-GBS patients.
Summary:
- The study analyzed data from 63 patients with CMV-associated GBS, confirming known clinical features.
- New insights into the epidemiology and prognostic factors of CMV-GBS were identified.
- Results suggest potential viral replication involvement in CMV-GBS neuropathology, warranting further research.
Impact:
- Enhances understanding of GBS etiology and patient outcomes.
- Provides valuable data for clinical management and future research directions in CMV-GBS.
- Highlights the need for further investigation into the role of viral replication in GBS pathogenesis.
More Related Videos
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
08:08qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
Published on: July 9, 2014
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:14Myocarditis III: Medical Management